Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The psoriasis market is undergoing significant expansion, with a trajectory that points to continuous growth from $23.87 billion in 2023 to an anticipated $39.17 billion by 2028. A compound annual growth rate (CAGR) of 10.3% reflects this market's dynamic nature, responding to numerous drivers and trends influencing its course. Expansion within this market coincides with rising global awareness, cutting-edge therapeutic developments, and shifts within healthcare delivery systems.
Renowned for being a comprehensive repository of market research, a fresh publication delineating the global psoriasis market's landscape has been integrated into our extensive portfolio of research reports. This addition imparts vital statistics and insightful analyses that highlight psoriasis market segments, industry trends, and future opportunities. The accelerated growth rate and burgeoning prevalence underscore the urgency for stakeholders to understand the intricacies of this market.
Fueled by biologic therapies and the prominence of personalized medicine, the market shows an upward trend powered by medical innovation. The landscape of treatment, dominated by interleukin inhibitors and tumor necrosis factor inhibitors, evolves with the integration of artificial intelligence to refine psoriasis management.
The population affected by psoriasis worldwide reaches into the millions, reflecting the need for expansive and inclusive treatment strategies. Consumer education and healthcare access improvement are pivotal factors in this growth narrative, propelling market dimensions to new heights.
The exhaustive report provides insights into the driving forces bolstering market growth, including the advancing geriatric demographic, susceptible to exacerbating conditions that affect psoriasis. This demographic shift, amidst a backdrop of economic considerations and regulatory environments, shapes the contours of market progress.
Despite robust progress, the psoriasis market faces cost-related impediments, with treatment expenditures presenting barriers to accessibility. However, trends such as combination therapy hold the promise of enhancing the efficacy and reach of psoriasis care. Path-breaking treatments receiving regulatory nods forge pathways for treatment access and signify a market responsive to health care needs.
With a regional lens focusing on accelerated growth in the Middle East and North America's prevailing market supremacy in 2023, the report provides a meticulous geographic analysis. Particular attention is paid to countries spearheading market advancements, examining the nexus of market forces in operation.
Key Highlights
- Market size surge from $23.87 billion in 2023 to $39.17 billion by 2028
- Projected CAGR of 10.3% from 2024 to 2028
- Innovative therapies and rise of personalized medicine as significant trends
- Growing incidence and awareness of psoriasis globally
- Influence of geriatric population on market growth
- Cost constraints as potential growth inhibitors
- Combination therapy seen as an emerging market trend
- Steady increase in worldwide regulatory approvals for new treatments
- Expanded focus on North America and fast-growing Middle East region.
A selection of companies mentioned in this report includes
- AbbVie Inc.
- Pfizer Inc.
- Novartis AG
- Eli Lilly and Company
- Celgene Corporation
- Johnson & Johnson
- Amgen Inc.
- Boehringer Ingelheim GmbH
- Merck & Co. Inc.
- Janssen Biotech Inc.
- Takeda Pharmaceutical Company Limited
- Stiefel Laboratories Inc.
- AstraZeneca Inc.
- Union Chimique Belge SA
- Sun Pharmaceutical Industries Ltd.
- Forward Pharma AS
- Almirall SA
- Bausch Health Companies Inc.
- Biogen Inc.
- Biocon Biopharmaceuticals Pvt. Ltd.
- Celltrion Inc.
- Dr.Reddy's Laboratories Inc.
- Arcutis Biotherapeutics Inc.
- Bayer AG
- Bristol Myers Squibb Co.
- Dermira Inc.
- Galderma SA
- GlaxoSmithKline Plc
- Incyte Pharmaceuticals Corp.
- LEO Pharmacy
For more information about this report visit https://www.researchandmarkets.com/r/gn5soa
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
